Cognitive Behavioral Therapy for Treatment of Pathological Gambling

Status Completed

Clinical Trial Summary

This study will determine the effectiveness and cost-effectiveness of three different treatment strategies in reducing gambling behaviors.

Clinical Trial Description

The number of pathological gamblers in the United States is steadily growing, leading to significant financial, psychological, and public health consequences. However, studies examining the effectiveness of treatment interventions for pathological gamblers are limited. This study will compare the effectiveness of three different treatment strategies, including referral to Gambler's Anonymous (GA), a self-help manual, and cognitive behavioral therapy (CBT), in reducing gambling behaviors and other problems related to pathological gambling.

This study will last 8 weeks. Participants will be randomly assigned to one of three interventions. Group 1 participants will be referred to GA and 8 weeks of CBT, which focuses on teaching skills to help reduce gambling urges and develop alternative behaviors to gambling. Group 2 participants will be referred to GA and given an 8-week self-help manual. Group 3 participants will be referred to GA alone. Questionnaires will be used to assess participants' gambling behavior and any personal, legal, or health problems they may be experiencing. The questionnaires will be completed at study entry, study completion, and at 6- and 12-month follow-up visits.

Participants will be asked to identify at least one person who knows about their gambling problem and will have regular contact with them during the study and for at least 1 year This person will be interviewed at the beginning of the study, and at Months 2, 6 and 12. Researchers will ask contact persons about participants' gambling behaviors, personal relationships, legal problems, use of health care and mental health services, and how the participant can be contacted if he or she moves.

For information on related studies, please follow these links:

http://clinicaltrials.gov/show/NCT00118391

http://clinicaltrials.gov/show/NCT00618462 ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Gambling

Clinical Trial Details

NCT number	NCT00158314
Study type	Interventional
Source	University of Connecticut Health Center
Contact
Status	Completed
Phase	Phase 1
Start date	March 1998
Completion date	November 2003

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02862821` - Biomarkers of Online Gambling Addiction	N/A
Completed	`NCT00967005` - N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers	Phase 2
Withdrawn	`NCT00370188` - Topiramate on Gambling-Related Behaviours	Phase 2
Completed	`NCT00069420` - Cognitive Motivational Behavior Therapy for Gamblers	Phase 1
Recruiting	`NCT05241041` - Effects of Positive Psychological Group Psychotherapy and Auricular Acupressure on Withdrawal Symptoms	N/A
Completed	`NCT02841566` - Comparative Study of the Link Between the Practice of Gambling and Money and Materialism Among Problem Gamblers and Non-problem Gamblers	N/A
Not yet recruiting	`NCT05630157` - Evaluation of Effectiveness of the Unplugged Program on Gambling Among Adolescents (GAPUnplugged)	N/A
Completed	`NCT00118391` - Cognitive-Behavioral Treatment of Gambling	Phase 1
Completed	`NCT03323606` - Online Interventions for Gamblers With and Without Co-occurring Problem Drinking	N/A
Completed	`NCT01219426` - A Transversal Study for the French Validation of Two Assessment Tools of Gambling Related Cognitions.	N/A
Completed	`NCT02250586` - Internet Based Cognitive Behavior Therapy for Concerned Significant Others of Problem Gamblers	N/A
Completed	`NCT02800096` - Online Interventions for Gamblers With and Without Co-occurring Mental Health Concerns	N/A
Completed	`NCT00685048` - Brief Therapies for Problem Gambling Substance Abusers	N/A
Completed	`NCT00078273` - Indicated Prevention With At-Risk Gamblers	Phase 2
Recruiting	`NCT05933356` - Effectiveness of Exergames on Cognitive, Social Functionamong Chronic Schizophrenia	N/A
Not yet recruiting	`NCT03493399` - Testing Interference-based Methods to Mitigate Gambling Craving - A Multiple Single Case Design	N/A
Not yet recruiting	`NCT06171516` - Internet-based Cognitive Behavioral Therapy for Individuals With Gambling Disorder in Indonesia	N/A
Recruiting	`NCT06195995` - Brain Mechanism and Intervention of Executive-control Dysfunction Among Gambling Disorder	N/A
Recruiting	`NCT06341504` - Prevention Messages for EGMs: Effects on Behaviours and Cognitions	N/A
Completed	`NCT02771886` - Evaluation of a Brief Surf the Urge Intervention	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.